Robert Townsend

Robert Townsend is a results driven leader with expertise in bringing novel technologies to market with 12+ years’ expertise and a proven track record. He has extensive experience in global clinical trial development, execution and management. Mr. Townsend’s most recent achievements include a PMA approval of the Cartiva SCI device, a VC backed start-up, that resulted in entity acquisition by Wright Medical for $435M. Mr. Townsend holds a Bachelors degree in Biology from Georgia Southern University.